KOPRAN RESEACH LABORATORIES LT
Company Profile:
Direct Answer: KOPRAN RESEARCH LABORATORIES LT is a **manufacturer (factory)**.
Company Introduction:
KOPRAN RESEARCH LABORATORIES LT, an entity within the Kopran Ltd group, is an Indian pharmaceutical company primarily engaged in the manufacturing sector. It operates as an integrated pharmaceutical manufacturer, specializing in the research, development, and production of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs).
The company is based in India and is recognized for its strong focus on pharmaceutical innovation, quality, and adherence to international regulatory standards. KOPRAN RESEARCH LABORATORIES LT produces a wide range of pharmaceutical products across various therapeutic areas, catering to both domestic and global markets. Its operations encompass advanced manufacturing facilities and a dedicated research and development infrastructure, underscoring its role as a key player in the pharmaceutical manufacturing industry.
Enterprise Products
Kopran Research Laboratories Ltd manufactures or sells products in the following categories:
Formulations:
Anti-Infectives
Cardiovascular
Anti-Diabetic
Pain Management
Gastrointestinal
Central Nervous System (CNS)
Respiratory
Vitamins and Minerals
Dermatology
Anti-Allergic
Anti-Malarial
Anti-Fungal
Anti-Inflammatory
Nutraceuticals
Active Pharmaceutical Ingredients (APIs):
The company produces various Active Pharmaceutical Ingredients, including but not limited to:
Azithromycin
Clarithromycin
Roxithromycin
Erythromycin
Fluconazole
Amlodipine
Losartan
Metformin
Paracetamol
Ibuprofen
Business Registration Information:
Manager:
Surendra Somani (Chairman & Managing Director)
Phone:
E-mail:
Official Website:
Address:
Parijat House, 1076, Dr. E. Moses Road, Worli, Mumbai – 400 018, India
This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.